A PHASE 1B STUDY OF MESENCHYMAL STROMAL CELL THERAPY FOR IDIOPATHIC PULMONARY FIBROSIS

被引：2
|
作者：
Chambers, D. C. [1 ,2 ]
Enever, D. [1 ]
Ilic, N. [3 ]
Sparks, L. [1 ]
Ayres, J. [1 ]
Yerkovich, S. T. [1 ,2 ]
Khalil, D. [4 ]
Atkinson, K. [5 ,6 ]
Hopkins, P. M. [1 ,2 ]
机构：
[1] Prince Charles Hosp, Queensland Lung Transplant Serv, Brisbane, Qld 4032, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[3] Mater Hosp, Mater Hlth Serv, Brisbane, Qld, Australia
[4] Translat Res Insitute, Mater Res Insitute, Brisbane, Qld, Australia
[5] Translat Res Insitute, Stem Cell Therapies Lab, Brisbane, Qld, Australia
[6] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia
来源：
CYTOTHERAPY | 2014年 / 16卷 / 04期
关键词：
D O I：
10.1016/j.jcyt.2014.01.029
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
17
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [1] A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis
    Chambers, Daniel C.
    Enever, Debra
    Ilic, Nina
    Sparks, Lisa
    Whitelaw, Kylie
    Ayres, John
    Yerkovich, Stephanie T.
    Khalil, Dalia
    Atkinson, Kerry M.
    Hopkins, Peter M. A.
    [J]. RESPIROLOGY, 2014, 19 (07) : 1013 - 1018
  • [2] A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Prasse, Antje
    Ramaswamy, Murali
    Mohan, Shaun
    Pan, Lin
    Kenwright, Andrew
    Neighbors, Margaret
    Belloni, Paula
    LaCamera, Peter P.
    [J]. PULMONARY THERAPY, 2019, 5 (02) : 151 - 163
  • [3] A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Antje Prasse
    Murali Ramaswamy
    Shaun Mohan
    Lin Pan
    Andrew Kenwright
    Margaret Neighbors
    Paula Belloni
    Peter P. LaCamera
    [J]. Pulmonary Therapy, 2019, 5 : 151 - 163
  • [4] Interferon-γ1b therapy in idiopathic pulmonary fibrosis -: A metaanalysis
    Bajwa, EK
    Ayas, NT
    Schulzer, A
    Mak, E
    Ryu, JH
    Malhotra, A
    [J]. CHEST, 2005, 128 (01) : 203 - 206
  • [5] Interferon-γ1b for the treatment of idiopathic pulmonary fibrosis
    Bouros, Demosthenes
    Antoniou, Katerina M.
    Tzouvelekis, Argyris
    Siafakas, Nikolaos M.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (10) : 1051 - 1060
  • [6] Interferon-γ-1b:: Therapeutic option in advanced idiopathic pulmonary fibrosis?
    Kroegel, C
    Mock, B
    Hengst, U
    Reissig, A
    [J]. RESPIRATION, 2004, 71 (06) : 656 - 657
  • [7] Effects of interferon-γ 1b on biomarker expression in patients with idiopathic pulmonary fibrosis
    Strieter, RM
    Starko, KM
    Enelow, RI
    Noth, I
    Valentine, VG
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (02) : 133 - 140
  • [8] Autologous Mesenchymal Stromal Cell Therapy for Idiopathic Nephrotic Syndrome: The MESNEPH Study
    Vivarelli, Marina
    Algeri, Mattia
    Perico, Norberto
    Casiraghi, Federica
    Emma, Francesco
    Introna, Martino
    Locatelli, Franco
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 827 - 828
  • [9] Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis
    Diptiman Chanda
    Ashish Kurundkar
    Sunad Rangarajan
    Morgan Locy
    Karen Bernard
    Nirmal S. Sharma
    Naomi J. Logsdon
    Hui Liu
    David K. Crossman
    Jeffrey C. Horowitz
    Stijn De Langhe
    Victor J. Thannickal
    [J]. Scientific Reports, 6
  • [10] Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis
    Chanda, Diptiman
    Kurundkar, Ashish
    Rangarajan, Sunad
    Locy, Morgan
    Bernard, Karen
    Sharma, Nirmal S.
    Logsdon, Naomi J.
    Liu, Hui
    Crossman, David K.
    Horowitz, Jeffrey C.
    De Langhe, Stijn
    Thannickal, Victor J.
    [J]. SCIENTIFIC REPORTS, 2016, 6
12345